Compare compounds
Select two compounds to view them side by side.
Semaglutide
RxCUI 199130
GLP-1 receptor agonist
peptide
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that increases insulin secretion, decreases glucagon secretion, and slows gastric emptying.
Used to improve glycemic control in adults with type 2 diabetes mellitus; also indicated for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity.
Tirzepatide
RxCUI 261551
GIP/GLP-1 receptor agonist
peptide
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist that improves glycemic control and supports weight loss.
Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes; and for chronic weight management in adults with obesity or overweight with weight-related comorbidities.